Y, W., Y, Z., C, S., J, L., & X, H. (2024). Development and Validation of a Nomogram to Predict the Risk of Special Uterine Leiomyoma Pathological Types or Leiomyosarcoma in Postmenopausal Women. Risk Management and Healthcare Policy, ume 17, 1669-1685.
Chicago-referens (17:e uppl.)Y, Wang, Zhao Y, Shi C, Li J, och Huang X. "Development and Validation of a Nomogram to Predict the Risk of Special Uterine Leiomyoma Pathological Types or Leiomyosarcoma in Postmenopausal Women." Risk Management and Healthcare Policy ume 17 (2024): 1669-1685.
MLA-referens (9:e uppl.)Y, Wang, et al. "Development and Validation of a Nomogram to Predict the Risk of Special Uterine Leiomyoma Pathological Types or Leiomyosarcoma in Postmenopausal Women." Risk Management and Healthcare Policy, vol. ume 17, 2024, pp. 1669-1685.
